Shellback Capital’s Thermo Fisher Scientific TMO Stock Holding History

Shellback Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,322	Closed	-$22.6M	–	131
2025 Q1	$22.6M	Buy	+45,322	New	+$24.5M	2.19%	16
2024 Q2	–	Sell	-11,799	Closed	-$6.86M	–	155
2024 Q1	$6.86M	Buy	11,799 +10,706	+980%	+$6.01M	0.46%	68
2023 Q4	$580K	Buy	+1,093	New	+$529K	0.05%	96
2022 Q4	–	Sell	-55,000	Closed	-$27.9M	–	100
2022 Q3	$27.9M	Buy	55,000 +15,000	+38%	+$8.39M	4.03%	4
2022 Q2	$21.7M	Buy	+40,000	New	+$22M	3.78%	6
2021 Q4	–	Sell	-92,009	Closed	-$52.6M	–	128
2021 Q3	$52.6M	Buy	+92,009	New	+$50.5M	3.07%	4
2018 Q4	–	Sell	-199,002	Closed	-$48.6M	–	93
2018 Q3	$48.6M	Buy	+199,002	New	+$45.8M	4.35%	1

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Shellback Capital's TMO Position: Q2 2025 in Review

Shellback Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 45,322 shares — an estimated $22.6M sold.

Shellback Capital first reported a position in TMO in Q3 2018 and held it in 7 quarters. The position peaked at $52.6M in Q3 2021. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Shellback Capital reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Shellback Capital sold 45,322 Thermo Fisher Scientific shares in Q2 2025, an estimated $22.6M.
Shellback Capital first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 7 quarters.
Shellback Capital's Thermo Fisher Scientific position peaked at $52.6M in Q3 2021.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Shellback Capital's 13F filing for Q2 2025, filed 14 Aug 2025.